Keywords: nicox, complete, enrollment, ph, iii, oa, trial
NicOx complete enrollment in Ph III OA trial
Article | 28 July 2008
France-based firm NicOx has completed the enrollment of 417 osteoarthritis patients with controlled hypertension in two clinical pharmacology studies in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
